Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
Bebtelovimab
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:developedBy |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:drugClass |
gptkb:monoclonal_antibody
|
| https://www.w3.org/2000/01/rdf-schema#label |
BT-100
|
| gptkbp:mechanismOfAction |
neutralizes SARS-CoV-2 virus
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
emergency use authorization (revoked)
|
| gptkbp:target |
gptkb:SARS-CoV-2_spike_protein
|
| gptkbp:usedFor |
gptkb:COVID-19
|
| gptkbp:bfsParent |
gptkb:Epson_Moverio
gptkb:Epson_Moverio_smart_glasses |
| gptkbp:bfsLayer |
7
|